Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
McKesson
Mallinckrodt
AstraZeneca
Medtronic

Last Updated: May 21, 2022

CLINICAL TRIALS PROFILE FOR PROTOPIC


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Protopic

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00106496 ↗ A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis Completed Astellas Pharma Inc Phase 4 2004-10-01 The purpose of the study is to determine the impact of topical corticosteroids on the safety and effectiveness of Protopic Ointment in the short-term treatment of moderate to severe Atopic Dermatitis and to compare the safety and effectiveness of Protopic Ointment to placebo in the long-term management of Atopic Dermatitis
NCT00236171 ↗ Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test Completed Technische Universit├Ąt Dresden N/A 2004-09-01 The purpose of this study is to evaluate the efficacy of the topical therapies Protopic and Advantan as well as their combination against placebo in a Psoriasis Plaque Test
NCT00275535 ↗ The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients Completed Genzyme, a Sanofi Company Phase 4 2001-04-01 This study was done to find out which treatment, tacrolimus or sirolimus, leads to better long-term kidney function in kidney transplant patients.
NCT00275535 ↗ The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients Completed Roche Pharma AG Phase 4 2001-04-01 This study was done to find out which treatment, tacrolimus or sirolimus, leads to better long-term kidney function in kidney transplant patients.
NCT00275535 ↗ The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients Completed Wyeth is now a wholly owned subsidiary of Pfizer Phase 4 2001-04-01 This study was done to find out which treatment, tacrolimus or sirolimus, leads to better long-term kidney function in kidney transplant patients.
NCT00275535 ↗ The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients Completed Mayo Clinic Phase 4 2001-04-01 This study was done to find out which treatment, tacrolimus or sirolimus, leads to better long-term kidney function in kidney transplant patients.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Protopic

Condition Name

Condition Name for Protopic
Intervention Trials
Myelodysplastic Syndrome 15
Acute Myeloid Leukemia in Remission 12
Acute Myeloid Leukemia 11
Hematopoietic and Lymphoid Cell Neoplasm 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Protopic
Intervention Trials
Leukemia 36
Leukemia, Myeloid, Acute 26
Leukemia, Myeloid 26
Leukemia, Lymphoid 25
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Protopic

Trials by Country

Trials by Country for Protopic
Location Trials
United States 331
Spain 12
Italy 10
France 10
Canada 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Protopic
Location Trials
Texas 32
California 23
Pennsylvania 22
Washington 21
Florida 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Protopic

Clinical Trial Phase

Clinical Trial Phase for Protopic
Clinical Trial Phase Trials
Phase 4 12
Phase 3 9
Phase 2/Phase 3 3
[disabled in preview] 76
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Protopic
Clinical Trial Phase Trials
Completed 38
Recruiting 26
Active, not recruiting 16
[disabled in preview] 22
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Protopic

Sponsor Name

Sponsor Name for Protopic
Sponsor Trials
National Cancer Institute (NCI) 56
M.D. Anderson Cancer Center 20
Fred Hutchinson Cancer Research Center 19
[disabled in preview] 28
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Protopic
Sponsor Trials
Other 98
NIH 63
Industry 30
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Medtronic
Moodys
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.